Clinical Trial Update: Phase I, Pharmacokinetic, Pharmacodynamic Trial of PTK787 and Paclitaxel in Combination for Advanced Solid Tumors [Phase 1]

View source ↗

Summary

Phase I pharmacokinetic/pharmacodynamic study evaluating the combination of PTK787 (Vatalanib) with Paclitaxel in patients with advanced solid tumors has been c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Carcinoma

Drugs mentioned

• PACLITAXEL (PACLITAXEL)
• PTK787 (Vatalanib) (Vatalanib)

Snippet

Sponsor: Indiana University School of Medicine | Conditions: Neoplasm Metastasis, Carcinoma | Phase 1 | Status: COMPLETED